Companies running private Medicare and Medicaid insurance plans inaccurately list many mental health professionals as being available to treat the plans’ members, a new federal watchdog report says.

AbbVie said its Rinvoq showed superiority over the company’s previous bestselling drug Humira in a head-to-head trial. Results showed that 43% of patients compared to 22% of patients on Humira ...

Looking past the richness of content seemingly unrelated to what we do in pharma is a huge miss. Spaces like Blackweek can provide us with that understanding and inspiration.

Nationwide, states are racing to win their share of a new $50 billion rural health fund. But helping rural hospitals, as originally envisioned, is quickly becoming a quaint idea.

The Idaho Medical Freedom Act makes it illegal to require anyone to take a vaccine or receive “medical intervention.” Leslie Manookian, the activist behind the law, hopes to make it a “societal norm” ...

The red panda character with neuroblastoma helps young patients cope in this effort from Neon and United Therapeutics.

While the AI convo often revolves around generative AI, it’s the AI systems capable of powering the future of marketing that generate the most excitement. AI will replace sales reps as the center of ...

Newsom vetoed a bill that would have required insurers to cover, and pharmacists to dispense, 12 months of hormone therapy at one time to transgender patients and others.

Acadia Pharmaceuticals CEO Catherine Owen Adams breaks down the company’s recent rebrand, its expansion into rare disease marketing and how it’s using AI.

President Trump wants to lower GLP-1 prices; Novo Nordisk hires new corporate affairs lead; FDA announces priority drug review candidates.

Underpinning the core of the campaign is the focus on making brain health accessible and enjoyable for older adults — whether through gaming or taking multivitamins.

The company’s recent creator effectiveness report underscored the need for dependable measurement in the category.